IRIDEX Corporation today reported financial results for the fourth quarter and year ended January 2, 2016.
Category: News
Increase in the number of dog attacks on guide dogs in the UK
Reported dog attacks on guide dogs have risen significantly over a five year period, finds a study published online in the journal Veterinary Record.
NovaBay Pharmaceuticals Reports 2015 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical Company focusing on commercializing its prescription Avenova® Lid and Lash Cleanser for the domestic eye care market, reports financial results for the three and 12 months ended December 31, 2015, and provides a business update. Fourth Quarter 2015 versus Third Quarter 2015 Avenova Highlights 41% increase in sales to a record $1.6 million 29% increase in the number of optometrists and ophtha
Second Sight Reports Fourth Quarter and Year End 2015 Financial Results
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today repor…
Open Spigot on Novartis’ Pipeline
(MedPage Today) — Novartis exec says pipeline is promising
Understanding the mechanism of rare blinding disorder passed from parents to their children
Scientists have identified a key mechanism that damages the cornea in Meesmann epithelial corneal dystrophy, a rare blinding disorder, which is passed from parents to their children.
Global Contact Lenses & Intraocular Lenses Market – Expected to Grow to US$ 20,050.9 Million by 2019 at a CAGR of 8.4% – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/nhqn5v/global_contact) has announced the addition of the “Global Contact Lenses & Intraocular Lenses Market Assessment & Forecast: 2015-2019” report to their offering. The North American market is anticipated to continue leading in terms of value due to ease of availability, higher awareness and diagnosis, greater number of ophthalmologists and optometrists per 1000 people as compared to other regi
Current vision screening recommendations for older adults have merit
The chair of ophthalmology at the University of Michigan examined a recent report investigating the value of vision screening for older adults with no symptoms.
Glaukos to Present at 28th Annual Roth Conference
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
USPSTF: Insufficient Data for Vision Screening in Adults
USPSTF update said trials show that screening in asymptomatic older adults does not improve patient outcomes and may come with harms. Medscape Medical News
Evidence insufficient to make recommendation regarding screening for impaired vision in older adults
The U.S. Preventive Services Task Force (USPSTF) has concluded that the current evidence is insufficient to assess the balance of benefits and harms of screening for impaired visual acuity…
Aflibercept Best in Diabetics With Bad Baseline Vision?
Final results from a trial comparing aflibercept, bevacizumab, and ranibizumab in diabetic macular edema confirm all three drugs are similar, but aflibercept is best in those with worse baseline vision, says lead researcher. Medscape Medical News
HHS Announces Agreement on Health Data Interoperability
(MedPage Today) — Providers, vendors agree to prevent information blocking, standardize programming
First Patients in Presbia Microlens FDA Study Complete 12-Month Postoperative Visits
DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced today that all subjects treated as part of the first stage of its U.S. Food and Drug Administration (FDA) pivotal study completed their 12-month postoperative visits, a significant milestone in the FDA approval process of its Presbia Flexivue Microlens™. The Presbia Flexivue Microlens is a revolutionary optical lens implant for treating presbyopia, the age-related l
Preceyes, Nightstar partner to develop drug delivery technology for ocular surgery
Preceyes B.V. (NL) and Nightstar (UK) have entered into a collaboration for the development of a high-precision drug delivery technology in the eye. Nightstar will use the Preceyes robotic device to further refine the delivery of gene therapy to the su…
DME Drugs Equally Effective at 2 Years
(MedPage Today) — But more adverse events seen with Lucentis versus Eylea
Second Sight to Discuss Fourth Quarter and Year End 2015 Financial Results on March 3, 2016 Conference Call
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year end 2…
Clearside Biomedical, Inc. Announces Appointment of Richard J. Croarkin to the Board of Directors
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, a late-stage clinical biopharmaceutical company developing first-in-class drug therapies for the eye, announces that Richard J. Croarkin is joining its Board of Directors.
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the fourth quarter and year ended December 31, 2015. “2015 was highlighted by the filing of our NUPLAZID™ (pimavanserin) New Drug Application for Parkinson’s disease psychosis and the designation of Priority Review b
Inotek Pharmaceuticals to Present at Cowen and Company’s 36th Annual Health Care Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–David P. Southwell, President and CEO of Inotek, will present at Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7th, 2016 at 2:00 ET at the Boston Marriott Copley Place Hotel